Colchicine in Decrease of Perivascular Inflammation Index on Coronary CTA: A Randomized Open-label Trial
Status:
Recruiting
Trial end date:
2025-03-07
Target enrollment:
Participant gender:
Summary
Evaluate the effectiveness of colchicine in reducing coronary perivascular inflammation in
patients with documented atherosclerosis and coronary inflammation after 12 months of the use
0.5mg dose once a day in patients undergoing elective coronary CT angiography